Robert Kramer, EVP Corporate Svs. Division at Emergent BioSolutions Inc. (EBS), sold 28,000 shares at $14.82 ($415K) on 2012-09-06, disclosed to the SEC on 2012-09-10.
Open-market sale of $415k EBS by EVP Corporate Svs. Division. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| EBS | SELL | 2021-01-19 | $4.0M | — | Filing → |
| EBS | SELL | 2016-04-08 | $847K | — | Filing → |
| EBS | SELL | 2016-04-05 | $3.0M | — | Filing → |